A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions

Vincent W. Vanek, Douglas L. Seidner, Penny Allen, Bruce Bistrian, Sharon Collier, Kathleen Gura, John M. Miles, Christina J. Valentine, Marty Kochevar

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

The currently available, standard soybean oil (SO)-based intravenous fat emulsions (IVFEs) meet the needs of most parenteral nutrition (PN) patients. There are alternative oil-based fat emulsions, such as medium-chain triglycerides (MCTs), olive oils (OOs), and fish oils (FOs), that, based on extensive usage in Europe, have an equivalent safety profile to SO. These alternative IVFEs are metabolized via different pathways, which may lead to less proinflammatory effects and less immune suppression. These alternative oil-based IVFEs are not currently available in the United States. Many patients who require IVFEs are already in a compromised state. Such patients could potentially have better clinical outcomes when receiving one of the alternative IVFEs to diminish the intake of the potentially proinflammatory ω-6 fatty acid-linoleic acid-which comprises more than 50% of the fatty acid profile in SO. Further research is needed on these alternative oil-based IVFEs to identify which IVFE oils or which combination of oils may be most clinically useful for specific patient populations.

Original languageEnglish (US)
Pages (from-to)150-192
Number of pages43
JournalNutrition in Clinical Practice
Volume27
Issue number2
DOIs
StatePublished - Apr 2012

Fingerprint

Intravenous Fat Emulsions
Oils
Soybean Oil
Fatty Acids
Fish Oils
Parenteral Nutrition
Linoleic Acid
Emulsions
Triglycerides
Fats
Safety

Keywords

  • fat emulsions
  • fatty acids, omega-3
  • fatty acids, omega-6
  • lipids
  • parenteral nutrition
  • parenteral nutrition solutions

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Vanek, V. W., Seidner, D. L., Allen, P., Bistrian, B., Collier, S., Gura, K., ... Kochevar, M. (2012). A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions. Nutrition in Clinical Practice, 27(2), 150-192. https://doi.org/10.1177/0884533612439896

A.S.P.E.N. position paper : Clinical role for alternative intravenous fat emulsions. / Vanek, Vincent W.; Seidner, Douglas L.; Allen, Penny; Bistrian, Bruce; Collier, Sharon; Gura, Kathleen; Miles, John M.; Valentine, Christina J.; Kochevar, Marty.

In: Nutrition in Clinical Practice, Vol. 27, No. 2, 04.2012, p. 150-192.

Research output: Contribution to journalArticle

Vanek, VW, Seidner, DL, Allen, P, Bistrian, B, Collier, S, Gura, K, Miles, JM, Valentine, CJ & Kochevar, M 2012, 'A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions', Nutrition in Clinical Practice, vol. 27, no. 2, pp. 150-192. https://doi.org/10.1177/0884533612439896
Vanek, Vincent W. ; Seidner, Douglas L. ; Allen, Penny ; Bistrian, Bruce ; Collier, Sharon ; Gura, Kathleen ; Miles, John M. ; Valentine, Christina J. ; Kochevar, Marty. / A.S.P.E.N. position paper : Clinical role for alternative intravenous fat emulsions. In: Nutrition in Clinical Practice. 2012 ; Vol. 27, No. 2. pp. 150-192.
@article{bd62ca28234a429d907f67420b6349ab,
title = "A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions",
abstract = "The currently available, standard soybean oil (SO)-based intravenous fat emulsions (IVFEs) meet the needs of most parenteral nutrition (PN) patients. There are alternative oil-based fat emulsions, such as medium-chain triglycerides (MCTs), olive oils (OOs), and fish oils (FOs), that, based on extensive usage in Europe, have an equivalent safety profile to SO. These alternative IVFEs are metabolized via different pathways, which may lead to less proinflammatory effects and less immune suppression. These alternative oil-based IVFEs are not currently available in the United States. Many patients who require IVFEs are already in a compromised state. Such patients could potentially have better clinical outcomes when receiving one of the alternative IVFEs to diminish the intake of the potentially proinflammatory ω-6 fatty acid-linoleic acid-which comprises more than 50{\%} of the fatty acid profile in SO. Further research is needed on these alternative oil-based IVFEs to identify which IVFE oils or which combination of oils may be most clinically useful for specific patient populations.",
keywords = "fat emulsions, fatty acids, omega-3, fatty acids, omega-6, lipids, parenteral nutrition, parenteral nutrition solutions",
author = "Vanek, {Vincent W.} and Seidner, {Douglas L.} and Penny Allen and Bruce Bistrian and Sharon Collier and Kathleen Gura and Miles, {John M.} and Valentine, {Christina J.} and Marty Kochevar",
year = "2012",
month = "4",
doi = "10.1177/0884533612439896",
language = "English (US)",
volume = "27",
pages = "150--192",
journal = "Nutrition in Clinical Practice",
issn = "0884-5336",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - A.S.P.E.N. position paper

T2 - Clinical role for alternative intravenous fat emulsions

AU - Vanek, Vincent W.

AU - Seidner, Douglas L.

AU - Allen, Penny

AU - Bistrian, Bruce

AU - Collier, Sharon

AU - Gura, Kathleen

AU - Miles, John M.

AU - Valentine, Christina J.

AU - Kochevar, Marty

PY - 2012/4

Y1 - 2012/4

N2 - The currently available, standard soybean oil (SO)-based intravenous fat emulsions (IVFEs) meet the needs of most parenteral nutrition (PN) patients. There are alternative oil-based fat emulsions, such as medium-chain triglycerides (MCTs), olive oils (OOs), and fish oils (FOs), that, based on extensive usage in Europe, have an equivalent safety profile to SO. These alternative IVFEs are metabolized via different pathways, which may lead to less proinflammatory effects and less immune suppression. These alternative oil-based IVFEs are not currently available in the United States. Many patients who require IVFEs are already in a compromised state. Such patients could potentially have better clinical outcomes when receiving one of the alternative IVFEs to diminish the intake of the potentially proinflammatory ω-6 fatty acid-linoleic acid-which comprises more than 50% of the fatty acid profile in SO. Further research is needed on these alternative oil-based IVFEs to identify which IVFE oils or which combination of oils may be most clinically useful for specific patient populations.

AB - The currently available, standard soybean oil (SO)-based intravenous fat emulsions (IVFEs) meet the needs of most parenteral nutrition (PN) patients. There are alternative oil-based fat emulsions, such as medium-chain triglycerides (MCTs), olive oils (OOs), and fish oils (FOs), that, based on extensive usage in Europe, have an equivalent safety profile to SO. These alternative IVFEs are metabolized via different pathways, which may lead to less proinflammatory effects and less immune suppression. These alternative oil-based IVFEs are not currently available in the United States. Many patients who require IVFEs are already in a compromised state. Such patients could potentially have better clinical outcomes when receiving one of the alternative IVFEs to diminish the intake of the potentially proinflammatory ω-6 fatty acid-linoleic acid-which comprises more than 50% of the fatty acid profile in SO. Further research is needed on these alternative oil-based IVFEs to identify which IVFE oils or which combination of oils may be most clinically useful for specific patient populations.

KW - fat emulsions

KW - fatty acids, omega-3

KW - fatty acids, omega-6

KW - lipids

KW - parenteral nutrition

KW - parenteral nutrition solutions

UR - http://www.scopus.com/inward/record.url?scp=84859372220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859372220&partnerID=8YFLogxK

U2 - 10.1177/0884533612439896

DO - 10.1177/0884533612439896

M3 - Article

C2 - 22378798

AN - SCOPUS:84859372220

VL - 27

SP - 150

EP - 192

JO - Nutrition in Clinical Practice

JF - Nutrition in Clinical Practice

SN - 0884-5336

IS - 2

ER -